Mylan to Pay $736 Million for Matrix From Newbridge
Aug. 28 (Bloomberg) -- Mylan Laboratories Inc., the second- largest U.S. generic drugmaker, will buy control of Matrix Laboratories Ltd. for as much as $736 million, the biggest acquisition of an Indian pharmaceuticals company.
Mylan will...